Introduction
used as a specific marker to study autophagy [30, 31] 
. In mammalian cells, autophagy is shown to be activated by class III phosphatidylinositol-3 (PI-3) kinase complex containing
Vps34 and Beclin-1 [28, 29] ; Wortmannin, an inhibitor of class III PI-3 kinase has been used in several studies to suppress autophagy [32, 33] . In the present study, we injected rats with Wortmannin (15 g/kg, intraperitoneally) 30 min. before isolation of heart in order to suppress the autophagy elicited by ischaemic adaptation. 
Materials and methods

Animals
All animals used in this study received humane care in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adhered to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 1996 edition. Sprague Dawley male rats weighing between 250-300 gm were fed ad libitum regular rat chow with free access to water until the start of the experimental procedure. The rats were randomly assigned to one of the following three groups: normal control [N], I/R and ischaemic adaptation.
Isolated working heart preparation
In vivo BAG-1 siRNA treatment
Survival surgeries in animals were performed as mentioned in our previous studies [36] . 
-m Z-steps. Inset 'ZX' presented in the panel H is ZX optical re-slicing of the region of interest (ROI) indicated in the panel with arrows (Note blue channel has been excluded). Spatial colocalization of BAG-1 (green channel) and LC3-II (red channel) in the panel H (ZX) appears in yellow colour as a result of interference between green and red colours. Pearson's correlation coefficient for signals of green and red channels in the indicated area is r ϭ 0.29. Processing and analysis of digital images, including colocalization of immunostained BAG-1 and LC3 was conducted with SimplePCI High
Cell survival assay
At the end of experimentation, cells were washed with phosphate buffered saline (PBS). Viability of cells was studied using MTT Cell Proliferation Assay kit (Cayman Chemical Company, Ann Arbor, MI, USA) as mentioned.
Cell death assay
Cell death analysis was performed with the spent culture medium as substrate with lactate dehydrogenase (LDH) Cytotoxicity Assay kit (Cayman Chemical Company) as mentioned.
Immunofluorescence staining in H9c2 cells
Results
Myocardial adaptation to ischaemic stress enhances autophagy
In this study, when isolated rat hearts were subjected to 30 
Inhibition of autophagy inhibits BAG-1 expression
Treatment with Wortmannin significantly attenuated adaptationinduced improvement in cardiac functional parameters such as left ventricular developed pressure and aortic flow (Fig. 4) . However, heart rate and coronary flow were not significantly affected by Wortmannin treatment (Fig. 4) . Also, Wortmannin treatment partially abolished the adaptation-induced reduction of infarct size (Fig. 5A and B) . Western blot analyses show that treatment with Wortmannin attenuated cardiac adaptation-induced LC3-II, Beclin-1 and BAG-1 (Fig. 5C-F) .
In vivo treatment with BAG-1 siRNA attenuated autophagy in the myocardium Fig. 8A and B (Fig. 8E) . (Fig. 8F) [17] , and recently, the protective effect of autophagy has been demonstrated under anoxia-reoxygenation in isolated cardiomyocytes [37] .
Hypoxic adaptation in cardiac myoblast cells induces autophagy and BAG-1
Our in vivo study results show that cardiac adaptation induced autophagy in association with BAG-1 protein. These results were
Fig. 1 Ischaemic adaptation induces autophagy. (A) -Cytoplasmic extract from left ventricular tissue was isolated, proteins were separated by SDS-PAGE and analysed by Western immunoblotting using specific antibodies. (B-D) -Quantitative analysis of Western immunoblotting of LC3 (B), Beclin-1 (C) and BAG-1 (D); the results are represented as fold change in comparison to control heart samples. Quantitation of LC3 is calculated by analysing the expression ratio of LC3-II / LC3-I. The expression of Beclin-1 and BAG-1 is normalized with the expression of GAPDH. *P Ͻ 0.05 versus control. (E) -Transmission electron micrographs of left ventricular tissue sections showing autophagosomes, indicated by arrows in control (a) ischaemia and reperfusion (b) and ischaemic adaptation followed by I/R (c). Autophagosomes contain mitochondria (m) and partially degraded material, which is indicated by * in (b) and (c). Scale bar represents 2 . Results are representative images of three to five separate samples. C -Control, I/R -ischaemia and reperfusion, IA -Ischaemic adaptation followed by I/R. further tested in vitro using H9c2 cardiac myoblast cells. H9c2 cells were subjected to 30 min. of hypoxia followed by 60 min. of reoxygenation (H/R). The hypoxic adaptation was induced by three repeated cycles of 5 min. of hypoxia and 5 min. of reoxygenation preceding H/R. H/R in cardiac myoblast cells induced the expression of LC3-II, and BAG-1 proteins (Fig. 7A-C). However, when H9c2 cells were subjected to hypoxic adaptation preceding the H/R, LC3-II and BAG-1 proteins were significantly enhanced as shown by Western immunoblotting in Fig. 7A-C. In accordance with the results shown in Fig. 3, our immunofluorescence analyses of H9c2 cells showed that the expression of LC3 and BAG-1 was increased in cells subjected to hypoxic adaptation followed by H/R. Representative immunofluorescence images (Fig. 7D and E) showing the staining of BAG-1 and LC3, respectively, in cells subjected hypoxic adaptation. Figure 7F shows the co-localization BAG-1 and LC3 in H9c2 cells subjected to hypoxic adaptation. This indicates that the results obtained in cardiac myoblast cells are in consistent with the results obtained in rat myocardium.
BAG-1 siRNA treatment in cardiac myoblast cells attenuated hypoxic adaptation-induced autophagy
When cardiac myoblast cells are treated with either control or BAG-1 siRNA, the hypoxic adaptation-induced expression of BAG-1 protein was decreased in BAG-1 siRNA treated cells compared to control siRNA treated cells (
H/R-induced LDH release is significantly attenuated by hypoxic adaptation in myoblast cells (Fig. 8E). Hypoxic adaptation-induced attenuation of LDH release was blocked when the cells are treated with BAG-1 siRNA compared to control siRNA (Fig. 8E). Moreover, cell survival assay using 3Ј(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) in H9c2 cells indicated that the hypoxic adaptation-induced improvement in cell survival probability was attenuated by treating cells with BAG-1 siRNA relative to control siRNA
Discussion
A lot of work has been done on the mechanism of ischaemic adaptation-induced cardioprotection
In this study, our results reveal the following novel findings: (i) ischaemic adaptation of the myocardium enhances autophagy and BAG-1, (ii) autophagosomal membrane specific protein LC3-II interacts with BAG-1, (iii) inhibition of autophagy by treating rats with Wortmannin attenuates BAG-1 protein expression and (iv) suppression of BAG-1 protein expression by in vivo BAG-1 siRNA treatment into the myocardium attenuated adaptation-induced autophagy. Further, treatment with BAG-1 siRNA in H9c2 cardiac myoblast cells attenuated hypoxic adaptation-induced LC3-II and cell survival. © 2009 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 LC3-II interacts with BAG-1. Cytoplasmic extracts of the left ventricular tissue is immunoprecipitated with BAG-1 specific antibodies. BAG-1 immunoprecipitates were separated by SDS-PAGE, and Western immunoblotting was performed with specific antibodies. Results are representative images of three separate experiments. C -Control, I/RIschaemia and reperfusion, IA -Ischaemic adaptation followed by I/R, T -cytosolic extract from IA sample.
Is autophagy in the myocardium protective or detrimental?
Autophagy acts as cellular defence mechanism against bacterial toxins [33] . Autophagy is shown to be induced in several cardiac diseases like heart failure [9] , cardiac hypertrophy [10] and ischaemic cardiomyopathy [11] . [14] . Overexpression of Bnip3, a pro-apoptotic molecule present in the mitochondrial membrane, triggered up-regulation of autophagy and protected cardiac myocytes from I/R injury-related apoptosis [38] . A recent study demonstrates that autophagy elicited by hypoxia or ischaemia via AMP activated protein kinase-dependent mechanism may provide protective role against cardiac injury; but autophagy elicited by ischaemia followed by reperfusion occurring via Beclin-1-dependent mechanism may play a detrimental role in the myocardium [15] .
Hamacher-Brady et al. have demonstrated that enhancing autophagy protects against I/R injury in cardiac myocytes
In another study, reduction of autophagy by RNA interference of Beclin-1, a key molecule involved in mediating autophagy, © 2009 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 3 Colocalization of BAG-1 and LC3. Immunofluorescence imaging of the expression of BAG-1 (B) and LC3 (C) in tissue sections obtained from hearts subjected to ischaemia and reperfusion (I/R), ischaemic adaptation followed by ischaemia and reperfusion (IA), and from control (Con) rats. (A), (E) -counterstaining of nuclei with Hoechst 33342 (blue channel); (B), (F) -immunofluorescence staining of BAG-1 (Alexa 488, green channel); (C), (G) -immunofluorescence staining of LC3-II (Alexa 594, red channel); (D), (H) -overlay of blue, green and red channels; (K) -Nomarski interference contrast images of the specimens; L -overlay of images presented in the (D) and (K). Confocal images showing the colocalization of BAG-1 and LC3 in IA heart samples (E-H). Bars in the images (A), (B), (C), (D), (K) and (L) are representing 100 m. Bars in the images (E)-(H) are representing 10 m.
enhances cardiac cell survival [39] . In order to address the controversial role of autophagy in the myocardium, in the present study we examined the function of autophagy during cardiac adaptation to ischaemic stress. Our study, in accordance with previous results [14] , shows that autophagy was slightly up-regulated by I/R injury (Fig. 1) . In addition, our results indicate that cardiac adaptation to ischaemic stress further enhanced autophagy as demonstrated by the up-regulation of autophagosomal membrane specific protein LC3-II, and Beclin-1 (Fig. 1A-C) , and by the presence of autophagosomes (Fig. 1E) (Fig. 7) . These results suggest that cardiac adaptation, a state-of-the-art technique to protect the myocardium against I/R injury, may trigger cell survival at least in part via the up-regulation of autophagy.
. Further, hypoxic adaptation in cardiac myoblast cells induced the expression of LC3-II as shown by Western immunoblotting and immunoflorescence analyses
BAG-1, a co-chaperone, binds with autophagosomal membrane protein LC3
BAG-1 is a multifunctional pro-survival molecule that binds with
Bcl-2 and protects cells from apoptosis [21, 22] . BAG-1 functions as a nucleotide exchange factor of mammalian cytosolic Hsc70, thereby triggering substrate unloading from the chaperone [40] . BAG-1 is shown to promote the association of Hsp70/Hsc70 with proteasome in vitro [41] . The ubiquitin domain protein BAG-1 and the carboxyl terminus of the Hsc70-interacting protein (CHIP) ubiquitin ligase can cooperate to shift the activity of the Hsc70/Hsp70 chaperone system from protein folding to degradation [42] . BAG-1 has been shown to protect cardiac myocytes from simulated I/R injury-induced apoptosis in association with Hsp70 and Hsc70 chaperone molecules [23] . This BAG-1-mediated cardioprotection was shown to be critical upon cytoplasmic localization but independent of its association with proteasome as shown that BAG-1 induced cardioprotection was not affected by a BAG-1 deletion mutant lacking N-terminal ubiquitin-like domain, which mediates interaction with proteasome [23] . These results suggest that BAG-1 may provide a novel cardioprotective role, which may be independent of its association with proteasome [23] .
Recently, it has been shown that autophagy is being regulated by Bcl-2 binding Beclin-1 [25] . BAG-1 is shown to present in the molecular chaperone complex at the lysosomal membrane along with Hsp70 and Hsc70 [26] . In another study, it has been demonstrated that autophagosomal membrane contains significantly higher amount of Hsc70 proteins [27] (Fig. 2) . In addition, our co-immunofluorescence analysis shows that LC3 is co-localized with BAG-1 in the myocardium (Fig. 3) . However, it is not known that whether BAG-1 directly interacts LC3-II or indirectly through other molecules. BAG-1 is shown to exert many of its functions via interaction of heat shock protein Hsc70 [22] . Recently, it has been shown that Hsc70 is present in significantly higher level in autophagosomal membrane [27] . LC3-II is a specific molecule found in the autophagosomal membrane [29] . In our study, we found that Hsc70 co-immunoprecipitate with BAG-1. Based on the above evidence, we speculate that BAG-1 may interact with LC3 via Hsc70.
Inhibition of autophagy abolished the cardioprotective abilities of ischaemic adaptation and attenuated BAG-1 protein
In mammalian cells, autophagy is shown to be activated by class III PI3 kinase complex containing Vps34 and Beclin-1 [28, 29] , and it is suppressed by the treatment with PI3 kinase inhibitor Wortmannin [33, 36] (Fig. 4) and in myocardial infarct size (Fig. 5) . Our results are in accordance with other studies [43, 44] , where Wortmannin has been shown to abrogate the protective effects in the myocardium.
Though Wortmannin has been used as an inhibitor of autophagy in several studies [33, 36] , one cannot rule out the possibilities of other effects of Wortmannin in the myocardium. (Fig. 8) 
Role of BAG-1 in the induction of autophagy
N-normal, H/R-hypoxia and reperfusion, HA-hypoxic adaptation followed by H/R. (D-E) -Confocal microscopic images showing the expression of BAG-1 (D) and LC3 (E) in HA samples. (F) -Confocal microscopic images showing the colocalization of BAG-1 and LC3 in HA samples. Colocalization is indicated by arrows. Counterstaining of nucleus in images D-F was done with Topro-1-iodide (Invitrogen). Figures are representative images of three different samples. from cells and (iii ) improvement in cell survival
